Page 266 - The Vasculitides, Volume 1: General Considerations and Systemic Vasculitis

240 Clodoveo Ferri, Dilia Giuggioli and Marco Sebastiani
[20] Terrier B, Saadoun D, Sene D, et al. Efficacy and tolerability of rituximab with or

without PEGylated interferon alfa-2b plus ribavirin in severe hepatitis C virus-related
vasculitis: a long-term follow up study of thirty-two patients. Arthritis. Rheum. 2009;
60: 2531-2540.
[21] Dammacco F, Tucci FA, Lauletta G, et al. PEGylated interferon-alpha, ribavirin, and
rituximab combined therapy of hepatitis C virus-related mixed cryoglobulinemia: a
long-term study. Blood 2010; 116: 343-353.

Complimentary Contributor Copy